GABPB1 and neoplasm: Notably, in adenocarcinoma patients, the expression of GABPB1 was also significantly associated with molecular subtypes (Fig. 2C) and tumor pathway activation, such as apoptosis, the cell cycle and EMT (Fig. 2D).